Ultralife Corporation (ULBI) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is neutral — 1 Buy, 1 Sell.
Analysts estimate Earnings Per Share (EPS) of $0.50 and revenue of $0.16B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.38 vs est $0.50 (missed -24%). 2025: actual $-0.35 vs est $0.70 (missed -150%). Analyst accuracy: 0%.
ULBI Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to Ultralife Corporation in the past 3 months
EPS Estimates — ULBI
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.38
vs Est $0.50
▼ 31.6% off
2025
Actual –$0.35
vs Est $0.70
▼ 300.0% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — ULBI
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.164B
vs Est $0.161B
▲ 2.1% off
2025
Actual $0.191B
vs Est $0.212B
▼ 10.7% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
